PRINT THIS PAGE

Cautious optimism from Canadian venture capitalists

Venture capital investments may have been down in the third quarter relative to the same period of 2000, but Canadian VCs are cautiously positive, says this survey from Deloitte & Touche and the Canadian Venture Capital Association.

Canadian venture capitalists are focusing their energies on genomics and bioengineering following the high-tech downturn. Perhaps more interesting, however, is the fact that the survey found that VCs have earmarked the majority of their remaining capital for new investments rather than follow-on finance. 

Click here to view full survey (pdf 304KB)

© 2002 Deloitte & Touche. Deloitte & Touche refers to Deloitte & Touche LLP and related entities. All rights reserved.

With more than 5,400 people in more than 44 locations across the country, Deloitte & Touche is one of Canada's leading professional services firms. As part of Deloitte Touche Tohmatsu, a global leader in professional services with more than 92,000 people in over 132 countries

The CVCA believes that venture capital plays a significant role in assisting dynamic Canadian companies in the achievement of their growth objectives and is committed to the promotion and support of venture capital as a professional practice.